Clinical Study of Preoperative Prehabilitation Synchronized Neoadjuvant Chemotherapy for Gastric Cancer Patients

Table 2

Comparison of 6MWD after intervention between two groups of gastric cancer patients (m, ).

Group	Cases	Preoperation		Postoperation
		m,	95% CI	m,	95% CI
Control	58	460.7 ± 82.3	446.113–488.094	403.4 ± 74.9	386.447–421.312
Prehabilitation	62	499.9 ± 86.3	473.617–514.222	478.8 ± 74.6	465.736–499.458
t value		2.662		5.524
value		0.009		<0.001